Category: Disaster Response

Trump Bashes Cuomo For Wanting All States Treated Equally for ‘Chinese Virus’: ‘Keep Politics Out Of It’

President Donald Trump is keeping his fight with New York Governor Andrew Cuomo going, tussling over how to address the coronavirus pandemic.

“Cuomo wants “all states to be treated the same.” But all states aren’t the same,” Trump tweeted, before using a name for the disease critics have slammed as racist. “Some are being hit hard by the Chinese Virus, some are being hit practically not at all. New York is a very big “hotspot”, West Virginia has, thus far, zero cases. Andrew, keep politics out of it….”

Trump’s tweet is a continuation of the swipes he launched on Cuomo after Monday’s teleconference between the president and state governors across the country. Cuomo has repeatedly expressed frustration that the federal government isn’t doing enough to respond to the virus, so Trump accused him of being the one who has to “do more.”

Cuomo fired back by saying “YOU have to do something! You’re supposed to be the President.” He also said he’d be “happy” to do Trump’s job if the president hands control of the Army Corps of Engineers over to him.

[Mediaite]

Trump Offered ‘Large Sum’ to German Company for Exclusive Access to Coronavirus Vaccine Research

The Trump administration attempted to persuade a German firm developing a possible vaccine for coronavirus to move its research work to the United States, German officials said, raising fears in Berlin that President Trump was trying to assure that any inoculation would be available first, and perhaps exclusively, in the United States.

The offer arose from a March 2 meeting at the White House that included the chief executive of the German firm CureVac, Daniel Menichella. President Trump briefly attended the meeting and Vice President Mike Pence, who heads the White House coronavirus task force, was also there.

“We are very confident that we will be able to develop a potent vaccine candidate within a few months,” Mr. Menichella said in a statement on the day of the meeting.

But four days ago, CureVac announced that Mr. Menichella, an American, was leaving the biotechnology company, which he had headed for two years.

The announcement gave no reason for his sudden departure and said one of the firm’s founders, Ingmar Hoerr, would succeed him. It thanked Mr. Menichella for a variety of accomplishments, including “the recent start of our coronavirus vaccine program.”

On Sunday, the company issued a statement in Germany describing its vaccine work. “CureVac refrains from commenting on current media speculations and clearly rejects claims about the sale of the company or its technology,” it said.

White House officials did not immediately respond to requests for comment. But two senior American officials said that some of the German news accounts first reporting the story were overblown, particularly with regard to any effort by the United States to secure exclusive access to a vaccine.

The Trump administration has spoken with more than 25 companies that say they can help with a vaccine, one of the American officials said, and is open to speaking with others. Any solution, he said, would be shared with the world.

Nevertheless, Germany’s interior minister, Horst Seehofer, said that Chancellor Angela Merkel, who has a famously testy relationship with Mr. Trump, will lead a crisis meeting with ministers on Monday that will include discussion of a German defense strategy for the firm.

The coronavirus is no longer merely a health crisis, but “a question of national security,” Mr. Seehofer said Sunday. It is up to the government, he said, to ensure not only security of its borders and its food supply, but also “our medical products and our medicines.”

Asked by a reporter to confirm that the U.S. administration had tried to take over a German company researching vaccines, Mr. Seehofer responded that he had heard about the effort “from several members of the government and it will be discussed tomorrow in the crisis team.”

Another official, who asked not to be identified because he is not authorized to speak to the media, said the company was offered a “large sum” of money.

The privately held biotechnology firm has its headquarters in the southwestern city of Tübingen, Germany. It also has an office in Boston, where many of the nation’s leading biotech firms have operations around the Harvard and Massachusetts Institute of Technology campuses.

According to the German newspaper Die Welt am Sonntag, which first reported the story on Sunday, Mr. Trump offered CureVac roughly $1 billion in exchange for exclusive access to the vaccine. The newspaper quoted an unnamed German government source who said Mr. Trump wanted the resulting vaccine “only for the United States.”

But another German official, reached by The New York Times, said it was unclear whether the administration simply wanted the research work, and for any resulting production to be on American soil.

Mr. Menichella was one of several industry executives invited by the White House to meet Mr. Pence, members of the coronavirus task force and pharmaceutical executives and discuss strategies to quickly develop a vaccine, the company said on its website.

CureVac started research on a number of different vaccines and is now picking the two best prospects for clinical trials, the firm’s website indicates. The company hopes that by June or July it will have an experimental vaccine that could go into trials. Many other companies are also working on vaccines.

The Trump administration has been unusually aggressive in attempting to get American control of companies that deal in technology Mr. Trump views as central to American security.

In February, Attorney General William P. Barr suggested in a speech that the United States should find a way to take over two European telecommunications makers, Ericsson and Nokia, which are the main competitors of Huawei, the Chinese telecommunications giant that is wiring up nations around the world for 5G, or fifth generation, networks.

Mr. Pence later played down that suggestion. But the idea that the Trump administration was seeking to take control of a major European technological asset sent unsettling ripples across Europe.

And the move to secure the intellectual property of CureVac, whether for exclusive or general use, is bound to inflame that debate.

Die Welt reported that the German government was making counterbids to the company to persuade it to stay. German lawmakers began to issue statements on Sunday.

“The exclusive sale of a possible vaccine to the USA must be prevented by all means,” Karl Lauterbach, a German lawmaker who is also a professor of epidemiology, said on Twitter. “Capitalism has limits.”

Adding to the dismay in Germany was the fact that CureVac works closely with a taxpayer-funded government research organization, the Paul Ehrlich Institute for vaccines and biomedicines.

Peter Altmaier, Germany’s economy minister, praised the company for not being tempted by any American offer. “It was a great decision,” he said in a television talk show on Sunday night. “Germany is not for sale.”

Mr. Altmaier said the government would “make sure that the necessary help is available” to the company in developing the vaccine. And he warned that if any hostile offer was attempted, Germany would step in.

“When it’s about important infrastructure and national and European interest,” he said, “we will also act if we have to.”

CureVac’s main investor ruled out giving exclusive access to a future vaccine to one country.

“We want to develop a vaccine for the whole world, and not for individual states,” Christof Hettich, chief executive of Dievini Hopp Biotech Holding, told the newspaper Mannheimer Morgen.

German officials sounded unsure about the reassurances that the United States would share a vaccine if it were developed.

A spokesman for the German health ministry said that German government officials were in regular contact with CureVac, confirming a quote in the original Die Welt article.

“The federal government is very interested in vaccines and antiviral agents against the novel coronavirus being developed in Germany and Europe,” the spokesman was quoted as saying in the original article. “In this regard the government is in an intensive exchange with the company CureVac.”

[The New York Times]

Trump Caught Google Off Guard With a Bogus Coronavirus Site Announcement

President Donald Trump announced Friday that the US government’s coronavirus testing apparatus, which has lagged badly behind other developed nations, would soon get an assist from Google. The search and advertising giant will create a website, Trump said, that would help Americans figure out if they need a test for the virus, and if so where they can find one.

The only problem: There is no nationwide site like the one Trump described. And Google had no idea the president was going to mention one.

A source at Google tells WIRED that company leadership was surprised that Trump announced anything about the initiative at the press conference. What he did say was also almost entirely wrong. There will be a coronavirus testing site, not from Google but from Alphabet sister company Verily. “We are developing a tool to help triage individuals for Covid-19 testing,” Google tweeted in a statement. “Verily is in the early stages of development, and planning to roll testing out in the Bay Area, with the hope of expanding more broadly over time.”

Even that, though, was not the original plan. As the Verge reported Friday afternoon, Verily had intended the site for health care workers only. After Trump unexpectedly publicized the effort, Verily decided it will let anyone visit it, but can still only provide people with testing site information in the San Francisco area. Google and Verily did not respond to requests for comment. It’s unclear whether senior Google leadership was aware of Trump’s plans, but CEO Sundar Pichai apparently made no reference to it in a company-wide memo about its coronavirus efforts Thursday, which was first reported by CNBC. In the memo, Pichai told employees that “a planning effort is underway” for Verily to “aid in the COVID-19 testing effort in the US.”

The disconnect is especially odd given how extensively Trump and other White House officials touted the website during Friday’s press conference. Google had 1,700 engineers working on it, Trump said. By Sunday, offered Vice President Mike Pence, they would be able to announce timing for the site’s availability. Recently appointed White House coronavirus coordinator Debbie Birx walked through how the site would work. “Clients and patients and people who have interest can fill out a screening questionnaire,” she said. If the answers indicate that they have symptoms for Covid-19, the disease caused by the novel coronavirus, the site will direct them to the nearest drive-through testing site. Once tested, they’ll get results within 24 to 36 hours. It sounded a bit like Google Maps: Pandemic Edition.

It’s unclear at this point the extent to which the Verily site will reflect that description. It’s part of a larger coronavirus testing package the White House announced, including partnerships with pharmacy giants CVS and Walgreens and retailers Target and Walmart. The tests themselves will be provided by biotech companies like Roche Diagnostics, which received approval for its version earlier Friday.

That the White House is finally treating testing with any kind of urgency is a welcome, if belated, push. But the apparent miscommunication—or outright misrepresentation—may bode poorly for the administration’s broader efforts. “What we have learned from past public health emergencies is the importance of clear, consistent, and accurate information that the public can use,” says Christopher Friese, professor in the University of Michigan School of Nursing. Friese’s comment was specifically about the importance of clarity in a testing information website, but also seems to apply more broadly.

Important questions remain about the Verily site itself, like how it handles data. At Friday’s press conference, Birx held up a flowchart that suggested visitors would have to log into the website to use it. “It is critically important that Google does not collect any personally identifiable information at the coronavirus website,” says Marc Rothstein, president of the nonprofit Electronic Privacy Information Center. “And there should be no covert tracking techniques, such as the retention of IP addresses linked to identifiable users. Moreover, no one should be required to use a Google account to gain access to public health information.”

Most important, today’s White House presentation created confusion at a time when the US can least afford it. People will be looking for a site that tells them where to get tested; unless they live in a handful of zip codes, it will be useless to them for the foreseeable future. That Trump said untrue things about a focal point of his plan also does not engender confidence in the rest of the measures. The US needs reliable, wide-scale testing, now. Without that, the site issue is moot.

“Will patients who are indicated for testing actually be able to get tested,” says Friese. “There are ample credible reports that is not the case presently. If patients still cannot get tested, the website is nothing more than lipstick on a pig.”

Or, as it turns out, an empty lipstick tube.

[Wired]

Trump Snaps at ‘Nasty Question’ About Disbanding White House Pandemic Office in 2018

President Donald Trump snapped at a reporter’s “nasty question” about his administration decimating the White House pandemic department in 2018.

PBS News reporter Yamiche Alcindor asked Trump on Friday during a coronavirus press conference about his claim he takes no responsibility for problems with the response to the pandemic.

“My first question is you said that you don’t take responsibility but you did disband the White House pandemic office and the officials that were working in that office left this administration abruptly. So what responsibility do you take to that?” asked the PBS NewsHour reporter. “The officials that worked in that office said that the White House lost valuable time because that office was disbanded. What do you make of that?”

“Well, I just think it’s a nasty question because what we’ve done, and Tony [Fauci] had said numerous times that we saved thousands of lives because of the quick closing,” President Trump responded. “And when you say me, I didn’t do it. We have a group of people… I could have perhaps ask Tony about that because I don’t know anything about it. I mean you say we did that, I don’t know anything about it. It’s the administration, perhaps, they do that. You know people let people go.”

“You used to be with a different newspaper than you are now, you know things like that happen,” he continued, before adding, “We are doing a great job. Let me tell you, these professionals behind me and these great incredible doctors and business people, the best in the world, and I can say that whether it’s retailers or labs or anything you want to say.”

“These are the best in the world,” President Trump concluded. “We are doing a great job.”

[Mediaite]

Media

‘I don’t take responsibility at all’: Trump deflects blame for coronavirus testing fumble

President Donald Trump on Friday deflected blame for his administration’s lagging ability to test Americans for the coronavirus outbreak, insisting instead — without offering evidence — that fault lies with his predecessor, Barack Obama.

“I don’t take responsibility at all,” Trump said defiantly, pointing to an unspecified “set of circumstances” and “rules, regulations and specifications from a different time.”

The remarks from the president came in response to questions at a Friday press conference about the lack of widespread access to testing, an aspect of his administration’s coronavirus response that has been the subject of widespread, steady criticism. Administration officials told lawmakers yesterday that the U.S. tested about 11,000 people during the first seven weeks of the outbreak — roughly as many as South Korea is testing each day.

And Anthony Fauci, the head of the National Institute of Allergy and Infectious Diseases, told lawmakers on the House Oversight Committee on Thursday that “the system is not really geared to what we need right now” in and called the testing system “a failing.”

But Trump, who spent weeks downplaying coronavirus before declaring it a national emergency on Friday, argued that the health care system was not designed for an outbreak on the scale of coronavirus, “with the kind of numbers that we are talking about.”

The president kept his criticism lighter and more forward-looking at first, declaring that his administration is “leaving a very indelible print in the future in case something like this happens again.”

“That’s not the fault of anybody — and frankly the old system worked very well for smaller numbers, much smaller numbers but not for these kind of numbers,” he added.

But then Fauci stepped up to the mic to clarify his position, arguing that the CDC’s testing system, “for what it was designed for, it worked very well,” and maintaining that an “embrace” of the private sector was necessary for testing at the kind of scale needed for the fast-spreading coronavirus.

Then, Trump began pointing fingers.

“If you go back — please, if you go back to the swine flu, it was nothing like this. they didn’t do testing like this,” he interjected, referencing the 2009 H1N1 pandemic that sickened more than 60 million people between April 2009 and 2010. Trump asserted that the Obama administration “didn’t do testing” and that when “they started thinking about testing,” it was “far too late.”

He reiterated a claim made on Twitter earlier in the day, calling the Obama administration’s response to the swine flu outbreak “a very big failure,” though the H1N1’s fatality rate of .02 percent is much lower than the lowest fatality estimates for the coronavirus thus far.

Trump later got testy with another reporter who pressed him on whether he bore any responsibility for the surge in cases, noting that he’d disbanded the White House’s pandemic office.

Trump told the reporter, PBS NewsHour’s Yamiche Alcindor — with whom he’s butted heads with in the past — that her inquiry was a “nasty question.”

After noting that his administration had quickly acted to restrict travel from China, where the coronavirus outbreak originated, the president said he personally was not responsible for dissolving the Directorate for Global Health Security and Biodefense, which had been part of the National Security Council until his administration disbanded it and rolled its officials into another office.

[Politico]

Pence: ‘I don’t think there’s confusion’ after clarifications to Trump’s coronavirus address

Vice President Mike Pence on Thursday dismissed suggestions that there was confusion surrounding President Donald Trump’s address to the nation about coronavirus despite the administration having to later make clarifications about travel restrictions.

“I don’t think there’s confusion,” Pence, who is leading the administration’s response to the crisis, told CNN’s Alisyn Camerota on “New Day” Thursday. But he was unable to provide figures on how many Americans have been tested for the virus, which has been a key question as the crisis has spread throughout the country and disrupted everyday life.

Speaking to the nation Wednesday night, Trump announced that “all travel from Europe to the United States” would be banned for 30 days beginning Friday, with exceptions for the United Kingdom. After Trump’s remarks, the administration clarified that the travel restriction did not apply to Americans or US permanent residents, nor did it apply to all of Europe but to nations in the Schengen zone.

Trump was also forced to clarify he was not blocking goods from Europe, despite saying in his address that his ban would “apply to the tremendous amount of trade and cargo” across the Atlantic.

On CNN Thursday, Pence elaborated on the travel restrictions, saying that Americans coming home will be funneled through 13 different airports, where they will be screened for the novel coronavirus. Americans and legal residents returning to the US will be required to self-quarantine for 14 days, Pence said.

“We’ve recognized, our health experts tracking global data, that the epicenter of the coronavirus has shifted from China and South Korea to Europe,” the vice president said.

Pence also defended the administration’s handling of testing for the virus. The availability of test kits to health care providers has been one of the most scrutinized aspects of the federal government’s response to the crisis, leading to frustrations from state and local officials, and there has been confusion among Trump administration officials over the number of testing kits that have been mailed out.

Pence said he didn’t believe the numbers of tests being performed were declining, despite what was listed on the US Centers for Disease Control and Prevention’s website in recent days.

Asked how many tests have been done, Pence replied, “Well, I would leave that to the experts.”

As of Monday, public health labs in all 50 states and Washington, DC, are able to test for novel coronavirus, according to the CDC. But the vice president said Thursday it’s “going to take a few more days” to make commercial testing for COVID-19 widely and readily available for the general public.

“The overall recommendation to Americans is to use common sense, practice good hygiene, and keep a special eye on seniors with chronic underlying health conditions,” Pence said.

Speaking to CNN’s John Berman on “New Day” on Tuesday, Health and Human Services Secretary Alex Azar also was unable to say how many Americans have been tested.

As of Thursday morning, there have been 38 deaths and over 1,200 cases of coronavirus in the United States, according to CNN’s tally.

[CNN]

Trump calls coronavirus a ‘foreign virus’ in Oval Office address

President Donald Trump referred to the novel coronavirus as a “foreign virus” in his Oval Office address on Wednesday night.

The characterization of the global pandemic as a foreign virus aligns with how some Trump allies have described the coronavirus in recent days, which critics have called xenophobic.

“This is the most aggressive and comprehensive effort to confront a foreign virus in modern history,” the President said.

“I am confident that by counting and continuing to take these tough measures we will significantly reduce the threat to our citizens and we will ultimately and expeditiously defeat this virus.”

The rare Oval Office address to the nation by Trump came as his administration has faced harsh criticism for his response to the pandemic. The President said he was “marshaling the full power of the federal government” to confront the growing public health crisis, including a monthlong halt in travel from Europe to the United States.

The address came the same day the World Health Organization declared the virus a pandemic, with more than 1,200 cases in the US.

The outbreak has not just sparked fear and anxiety in countries like the US and the UK — it has also seen a rise in xenophobic and racist assaults against people of East Asian, and particularly Chinese, descent. And panic over the virus continues to pummel the Chinese business sector in cities like New York, where fear of the disease has driven people away from east Asian neighborhoods.

The President’s reference to the virus as “foreign” echoes a tweet he shared earlier this week promoting a US southern-border wall as a way to protect Americans from the “China Virus.”

Trump, adding his own comment to the tweet, said, “Going up fast. We need the Wall more than ever!”
The post was met with fierce pushback from critics, including Democratic presidential front-runner Joe Biden, who tweeted, “A wall won’t stop a virus. Racism won’t stop a virus.

“Do your job.”

[CNN]

Reality

Donald Trump referred to the novel coronavirus as a “foreign virus” in his Oval Office address on Wednesday night, echoing Fox News and Republicans who have sought to frame the Chinese people as “bat eaters” from an “uncivilized world.”

The White House had to issue a correction after Trump was unable to read directly from a teleprompter and announced he is banning goods trade from Europe although he is not banning goods trade from Europe.

“And these prohibitions will not only apply to the tremendous amount of trade and cargo but various other things as we get approval,” Trump said. “Anything coming from Europe to the United States is what we are discussing.”

The White House quickly noted that the restrictions were focused on people, not boxes, and Trump later appeared to clarify his remarks in a tweet.

Media

Trump snaps at CNN’s Acosta for asking about health officials contradicting his coronavirus claims

President Donald Trump snapped at CNN reporter Jim Acosta for asking about the White House’s own officials who contradict what the president says about the coronavirus.

“What do you say to Americans who are concerned that you’re not taking this seriously enough and that some of your statements don’t match what your health experts are saying?” asked Acosta.

“That’s CNN. Fake news,” Trump dismissed the question.

Trump was speaking after a meeting with Wall Street bank CEOs, which happened as the Dow Jones hit “bear market” territory at its close Wednesday. He took a few questions from the press during the photo opportunity, and Acosta asked the question. Trump was furious and kicked the press out.

“Tried to ask Trump to respond to Americans who are concerned he’s not taking situation seriously enough and that his statements don’t match what health experts are saying. He did not answer the question,” tweeted Acosta.

[Raw Story]

Media

White House told federal health agency to classify coronavirus deliberations

The White House has ordered federal health officials to treat top-level coronavirus meetings as classified, an unusual step that has restricted information and hampered the U.S. government’s response to the contagion, according to four Trump administration officials.

The officials said that dozens of classified discussions about such topics as the scope of infections, quarantines and travel restrictions have been held since mid-January in a high-security meeting room at the Department of Health & Human Services (HHS), a key player in the fight against the coronavirus.

Staffers without security clearances, including government experts, were excluded from the interagency meetings, which included video conference calls, the sources said.

“We had some very critical people who did not have security clearances who could not go,” one official said. “These should not be classified meetings. It was unnecessary.”

The sources said the National Security Council (NSC), which advises the president on security issues, ordered the classification.”This came directly from the White House,” one official said.

The White House insistence on secrecy at the nation’s premier public health organization, which has not been previously disclosed, has put a lid on certain information – and potentially delayed the response to the crisis. COVID19, the disease caused by the virus, has killed about 30 people in the United States and infected more than 1,000 people.

HHS oversees a broad range of health agencies, including the U.S. Centers for Disease Control and Prevention, which among other things is responsible for tracking cases and providing guidance nationally on the outbreaks.

The administration officials, who spoke to Reuters on condition of anonymity, said they could not describe the interactions in the meeting room because they were classified.

An NSC spokesman did not respond to questions about the meetings at HHS. But he defended the administration’s transparency across federal agencies and noted that meetings of the administration’s task force on the coronavirus all are unclassified. It was not immediately clear which meetings he was referring to.

“From day one of the response to the coronavirus, NSC has insisted on the principle of radical transparency,” said the spokesman, John Ullyot. He added that the administration “has cut red tape and set the global standard in protecting the American people under President Trump’s leadership.”

A spokeswoman for the HHS, Katherine McKeogh, issued a statement that did not address questions about classified meetings. Using language that echoed the NSC’s, the department said it that it agreed task-force meetings should be unclassified.

Critics have hammered the Trump administration for what they see as a delayed response to coronavirus outbreaks and a lack of transparency, including sidelining experts and providing misleading or incomplete information to the public. State and local officials also have complained of being kept in the dark about essential federal response information.

U.S. Vice-President Mike Pence, the administration’s point person on coronavirus, vowed on March 3 to offer “real-time information in a steady pace and be fully transparent.” The vice president, appointed by President Donald Trump in late February, is holding regular news briefings and also has pledged to rely on expert guidance.

The meetings at HHS were held in a secure area called a “Sensitive Compartmentalized Information Facility,” or SCIF, according to the administration officials.

SCIFs are usually reserved for intelligence and military operations. Ordinary cell phones and computers can’t be brought into the chambers. HHS has SCIFs because theoretically it would play a major role in biowarfare or chemical attacks.

A high-level former official who helped address public health outbreaks in the George W. Bush administration said “it’s not normal to classify discussions about a response to a public health crisis.”

Attendees at the meetings included HHS Secretary Alex Azar and his chief of staff Brian Harrison, the officials said. Azar and Harrison resisted the classification of the meetings, the sources said.

HHS did not make Azar or Harrison available for comment.

One of the administration officials told Reuters that when complex issues about a quarantine came up, a high-ranking HHS lawyer with expertise on the issue was not admitted because he did not have the proper security clearance. His input was delayed and offered at an unclassified meeting, the official said.

A fifth source familiar with the meetings said HHS staffers often weren’t informed about coronavirus developments because they didn’t have adequate clearance. He said he was told that the matters were classified “because it had to do with China.”

The coronavirus epidemic originated in China and the administration’s main focus to prevent spread early on was to restrict travel by non-U.S. citizens coming from China and to authorize the quarantine of people entering the United States who may have been exposed to the virus.

One of the administration officials suggested the security clearances for meetings at HHS were imposed not to protect national security but to keep the information within a tight circle, to prevent leaks.

“It seemed to be a tool for the White House – for the NSC – to keep participation in these meetings low,” the official said.

[Reuters]

Trump pushes back on Vanity Fair report he’s ‘melting down’ over coronavirus

President Trump pushed back on a Vanity Fair article Wednesday that reported he is “melting down” over the coronavirus.

The article, published Monday, cites a person close to the administration saying Trump is “definitely melting down over this,” referring to the coronavirus outbreak.

Trump hit back, saying that the magazine “will soon be out of business,” and claiming “their third rate Fake reporters, who make up sources which don’t exist, wrote yet another phony & boring hit piece.”

“The facts are just the opposite,” the president tweeted. “Our team is doing a great job with CoronaVirus!”

The article, written by Vanity Fair’s Gabriel Sherman, says the source close to the administration said the president is afraid journalists are trying to get coronavirus to infect him on Air Force One. The president also asked the Secret Service to set up a program and ban anyone who has a cough on the White House grounds, according to the story.  

White House press secretary Stephanie Grisham called the article “100% fake news” on Monday, the day it was published.

“@gabrielsherman did not reach out to me,” she said. “False & sensational writing on this topic is irresponsible. POTUS has spent plenty of time w the press pool – simply ask ur colleagues. Nothing about your little college essay is funny or true & I want a retraction.”

Trump has praised the government’s efforts to contain the virus and send out tests. The president decided against taking a test for the virus after his physician said he didn’t it wasn’t necessary.

“I don’t think it’s a big deal. I would do it. I don’t feel any reason. I feel extremely good. I feel very good, but I guess it’s not a big deal to get tested and it’s something I would do,” Trump told reporters Tuesday.

[The Hill]

1 … 5 6 7 8 9 … 12